Cargando…
Development of Preventive Vaccines for Hepatitis C Virus E1/E2 Protein
Hepatitis C virus (HCV) is responsible for a vast majority of liver failure cases. HCV is a kind of blood disease estimated to chronically infect 3% of the worlds population, causing significant morbidity and mortality. Therefore, a complete knowledge of humoral responses against HCV, resulting anti...
Autores principales: | Ghasemi, Faezeh, Ghayour-Mobarhan, Majid, Gouklani, Hamed, Meshkat, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Society of Pathology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339490/ https://www.ncbi.nlm.nih.gov/pubmed/30697280 |
Ejemplares similares
-
Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection
por: Ghasemi, Faezeh, et al.
Publicado: (2016) -
Design, Construction and Evaluation of 1a/JFH1 HCV Chimera by Replacing the Intergenotypic Variable Region
por: Ghasemi, Faezeh, et al.
Publicado: (2016) -
The Prevalence of Hepatitis C Virus in Mashhad, Iran: A Population-Based Study
por: Shakeri, Mohammad Taghi, et al.
Publicado: (2013) -
The role of human T-lymphotropic virus (HTLV) in cardiovascular diseases: A review of literature
por: Abolbashari, Samaneh, et al.
Publicado: (2018) -
The Prevalence of Hepatitis B Virus Infection in Mashhad, Iran: A Population-Based Study
por: Shakeri, Mohammad Taghi, et al.
Publicado: (2013)